Luoxin Pharmaceuticals Group Stock Co Ltd
SZSE:002793
Luoxin Pharmaceuticals Group Stock Co Ltd
SZSE:002793
Price:
4.93
CNY
-0.4%
Market Closed
Market Cap:
¥5.4B
Relative Value
The Relative Value of one
Luoxin Pharmaceuticals Group Stock Co Ltd
stock under the Base Case scenario is
5.95
CNY.
Compared to the current market price of 4.93 CNY,
Luoxin Pharmaceuticals Group Stock Co Ltd
is
Undervalued by 17%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
5.95
CNY
Undervaluation 17%
Multiples Across Competitors
Competitors Multiples
Luoxin Pharmaceuticals Group Stock Co Ltd Competitors
Luoxin Pharmaceuticals Group Stock Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Luoxin Pharmaceuticals Group Stock Co Ltd
SZSE:002793
|
5.4B CNY | 2.2 | -7.9 | -17.8 | -17.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
963B USD | 14.8 | 46.7 | 31.4 | 33.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
599.3B USD | 6.4 | 22.4 | 15.5 | 19.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
288.1B CHF | 4.7 | 30.6 | 12.9 | 15.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
250B CHF | 5.7 | 23 | 14.2 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.1B GBP | 5.4 | 31.2 | 17.3 | 24.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
300.9B USD | 4.6 | 16.5 | 10.2 | 12.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.7B USD | 2.6 | 17.8 | 7.4 | 9.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
